Cardiovascular disease itself (e.g., congestive heart failure; Seravalle et al., 2019), complicated by T2DM, can increase MSNA, making it difficult to demonstrate the direct effects of abnormal glucose/insulin metabolism on autonomic function. The gene discussed is INS; the disease is cardiovascular disorder.